Conventionally, CTCs have been captured or detected by targeting the melanoma-associated chondroitin sulphate proteoglycan (MCSP, HMW-MAA, CSPG4, NG2) [5,7,8,9,10,22,23,24]. The gene discussed is CSPG4; the disease is melanoma.